Doxazosin mesylate and Benazepril hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Doxazosin mesylate and Benazepril hydrochloride. Common interactions include drug effect increased among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people who take Doxazosin mesylate and Benazepril hydrochloride have. It is created by eHealthMe based on reports of 44 people who take Doxazosin mesylate and Benazepril hydrochloride from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 30, 2022

44 people who take Doxazosin mesylate and Benazepril hydrochloride together, and have interactions are studied.


What is Doxazosin mesylate?

Doxazosin mesylate has active ingredients of doxazosin mesylate. It is often used in high blood pressure. eHealthMe is studying from 10,742 Doxazosin mesylate users for its effectiveness, alternative drugs and more.

What is Benazepril hydrochloride?

Benazepril hydrochloride has active ingredients of benazepril hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 4,910 Benazepril hydrochloride users for its effectiveness, alternative drugs and more.

Number of Doxazosin mesylate and Benazepril hydrochloride reports submitted per year:

Doxazosin mesylate and Benazepril hydrochloride drug interactions.

Common Doxazosin Mesylate and Benazepril Hydrochloride drug interactions by gender *:

female:

  1. Drug effect increased
  2. Hypoglycaemia
  3. Mucosal dryness
  4. Petechiae
  5. Renal failure
  6. Vasculitic rash

male:

  1. Diarrhoea
  2. Nausea
  3. Vomiting
  4. Rash
  5. Stomatitis
  6. Blister
  7. Oedema peripheral
  8. Pain
  9. Abdominal distension
  10. Dyspnoea

Common Doxazosin Mesylate and Benazepril Hydrochloride drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Bilirubin conjugated increased
  2. Diabetes mellitus
  3. Haemoglobin decreased
  4. Lymphocyte count decreased
  5. Neutrophil count increased
  6. Abdominal pain
  7. Blood urea increased
  8. Diarrhoea
  9. Protein urine present
  10. Red blood cells urine positive

50-59:

  1. Stomatitis
  2. Type 2 diabetes mellitus
  3. Blindness unilateral
  4. Diabetes mellitus inadequate control
  5. Dry skin
  6. Epistaxis
  7. Optic ischaemic neuropathy

60+:

  1. Nausea
  2. Anaemia
  3. Rash
  4. Neck pain
  5. Abdominal distension
  6. Alopecia
  7. Arthralgia
  8. Arthritis
  9. Asthenia
  10. Chronic kidney disease

Common conditions people have *:

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 13.64%
  2. Heart Disease: 6 people, 13.64%
  3. Pain: 6 people, 13.64%
  4. Weakness: 4 people, 9.09%
  5. Lung Disorder (lung disease): 4 people, 9.09%
  6. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 9.09%
  7. Colon Cancer: 4 people, 9.09%
  8. Dizziness: 4 people, 9.09%
  9. High Blood Cholesterol: 4 people, 9.09%
  10. Productive Cough: 4 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Doxazosin mesylate and Benazepril hydrochloride?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Doxazosin mesylate and Benazepril hydrochloride interactions:

Browse all drug interactions of Doxazosin mesylate and Benazepril hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Doxazosin mesylate side effects:

Browse all side effects of Doxazosin mesylate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Benazepril hydrochloride side effects:

Browse all side effects of Benazepril hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Doxazosin mesylate interactions:

Browse all interactions between Doxazosin mesylate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Benazepril hydrochloride interactions:

Browse all interactions between Benazepril hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on doxazosin mesylate and benazepril hydrochloride (the active ingredients of Doxazosin mesylate and Benazepril hydrochloride, respectively), and Doxazosin mesylate and Benazepril hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Doxazosin mesylate and Benazepril hydrochloride.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: